Molecular characterization of phenylketonuria in Japanese patients

We characterized phenylalanine hydroxylase (PAH) genotypes of Japanese patients with phenylketonuria (PKU) and hyperphenylalaninemia (HPA). PKU and HPA mutations in 41 Japanese patients were identified by denaturing gradient gel electrophoresis and direct sequencing, followed by restriction fragment length polymorphism analysis to find a large deletion involving exons 5 and 6. Of 82 mutant alleles, 76 (92%) were genotyped showing 21 mutations. The major mutations were R413P (30.5%), R243Q (7.3%), R241 C (7.3%), IVS4nt-1 (7.3%), T278I (7.3%), E6nt-96A→g (6.1%), Y356X (4.9%), R111X (3.7%), and 442–706delE5/6 (2.4%). Eight new mutations (L52 S, delS70, S70P, Y77X, IVS3nt-1, A132 V, W187 C, and C265Y) and a polymorphism of IVS10nt-14 were detected. In vitro PAH activities of mutant PAH cDNA constructs were determined by a COS cell expression system. Six mutations, viz., R408Q, L52 S, R241 C, S70P, V388 M, and R243Q, had 55%, 27%, 25%, 20%, 16% and 10% of the in vitro PAH activity of normal constructs, respectively. The mean pretreatment phenylalanine concentration (0.83±0.21 mmol/l) of patients carrying the R408Q, R241 C, or L52 S mutation and a null mutation was significantly lower (P<0.0005) than that (1.99±0.65 mmol/l) of patients with both alleles carrying mutations associated with a severe genotype. Simple linear regression analysis showed a correlation between pretreatment phenylalanine concentrations and predicted PAH activity in 29 Japanese PKU patients (y=31.9–1.03x, r=0.59, P<0.0001). Genotype determination is useful in the prediction of biochemical and clinical phenotypes in PKU and can be of particular help in managing patients with this disorder.

[1]  S. R. Liu,et al.  Newborn screening for phenylketonuria in eleven districts. , 1986, Chinese medical journal.

[2]  Marvin B. Shapiro,et al.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.

[3]  K. Aoki,et al.  Outcome of the Patients Detected by Newborn Screening in Japan , 1988, Acta paediatrica Japonica : Overseas edition.

[4]  W. H. Lo,et al.  Missense mutations prevalent in Orientals with phenylketonuria: molecular characterization and clinical implications. , 1991, Genomics.

[5]  F. Güttler,et al.  Molecular basis of phenotypic heterogeneity in phenylketonuria. , 1991, The New England journal of medicine.

[6]  M. Shimada,et al.  A new single base substitution in a Japanese Phenylketonuria (PKU) patient , 1991, Brain and Development.

[7]  M. Harvey,et al.  Founder effect of a prevalent phenylketonuria mutation in the Oriental population. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Dworniczak,et al.  Two missense mutations causing mild hyperphenylalaninemia associated with DNA haplotype 12 , 1992, Human mutation.

[9]  Dong-hwan Lee,et al.  Frequency and distribution of phenylketonuric mutations in orientals , 1992, Human mutation.

[10]  P. Guldberg,et al.  Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. , 1993, Genomics.

[11]  P. Burgard,et al.  Genotype-phenotype correlations in phenylketonuria. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[12]  P. Guldberg,et al.  Molecular heterogeneity of nonphenylketonuria hyperphenylalaninemia in 25 Danish patients. , 1994, Genomics.

[13]  C. Graham,et al.  Non‐phenylketonuria hyperphenylalaninaemia in Northern Ireland: Frequent mutation allows screening and early diagnosis , 1994, Human mutation.

[14]  A. Masamune,et al.  Ectopic transcription: an application to the analysis of splicing errors in phenylalanine hydroxylase mRNA , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[15]  G. Isshiki,et al.  Molecular characterization of phenylketonuric mutations in Japanese by analysis of phenylalanine hydroxylase mRNA from lymphoblasts. , 1994, Human molecular genetics.

[16]  Evidence in Latin America of recurrence of V388M, a phenylketonuria mutation with high in vitro residual activity. , 1995, American journal of human genetics.

[17]  A. Brown,et al.  Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US population. , 1996, Pediatrics.

[18]  R. Matalon,et al.  Phenylalanine hydroxylase gene mutations in the United States: report from the Maternal PKU Collaborative Study. , 1996, American journal of human genetics.

[19]  P. Waters,et al.  Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations. , 1997, American journal of human genetics.

[20]  P. Knappskog,et al.  Phenylketonuria splice mutation (EXON6nt‐96Ag) masquerading as missense mutation (Y204C) , 1997, Human mutation.

[21]  M. Nagao.  A simple and rapid polymerase chain reaction‐based method for detecting a prevalent mutation (R413P) in Japanese phenylketonuria patients , 1997, Acta paediatrica Japonica : Overseas edition.

[22]  Piotr M. Nowacki,et al.  The PAH mutation analysis consortium database: update 1996 , 1997, Nucleic Acids Res..

[23]  P. Waters,et al.  Analysis of Phenylalanine Hydroxylase Genotypes and Hyperphenylalaninemia Phenotypes Using L-[1-13C]Phenylalanine Oxidation Rates in Vivo: A Pilot Study1 , 1997, Pediatric Research.

[24]  P. Guldberg,et al.  A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. , 1998, American journal of human genetics.